Classification
Compound class	Synthetic organic

IUPAC Name

(3R)-3-{[6-(4-methylphenyl)pyridin-3-yl]oxy}-1-azabicyclo[2.2.2]octane

Comments

AQW 051 is an α7 nicotinic acetylcholine receptor (nAChR) agonist from Novartis for the oral treatment of cognitive deficits in schizophrenia, Alzheimer's, and Parkinson's diseases. Structure first disclosed at March 2014 ACS meeting. The (3S) version is CID 71553840

Database Links
CAS Registry No.	669770-29-0 (source: Scifinder)
GtoPdb PubChem SID	178103943
PubChem CID	50914822
Search Google for chemical match using the InChIKey	NPDLTEZXGWRMLQ-IBGZPJMESA-N
Search Google for chemicals with the same backbone	NPDLTEZXGWRMLQ
Search UniChem for chemical match using the InChIKey	NPDLTEZXGWRMLQ-IBGZPJMESA-N
Search UniChem for chemicals with the same backbone	NPDLTEZXGWRMLQ